Next Article in Journal
A Mitochondria-Targeted Heptamethine Indocyanine Small Molecular Chelator for Attenuating Uranium Nephrotoxicity
Previous Article in Journal
A Phytochemical Analysis and the Pharmacological Implications of the Seagrass Halodule uninervis: An Overview
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Orodispersible Dosage Forms with Rhinacanthin-Rich Extract as a Convenient Formulation Dedicated to Pediatric Patients

by
Thongtham Suksawat
1,
Witold Brniak
2,*,
Ewelina Łyszczarz
2,
Małgorzata Wesoły
3,
Patrycja Ciosek-Skibińska
3 and
Aleksander Mendyk
2
1
Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand
2
Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland
3
Department of Microbioanalytics, Warsaw University of Technology, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2024, 17(8), 994; https://doi.org/10.3390/ph17080994 (registering DOI)
Submission received: 21 June 2024 / Revised: 22 July 2024 / Accepted: 25 July 2024 / Published: 27 July 2024
(This article belongs to the Special Issue Orodispersible Tablets: New Advances in Preparation Technologies)

Abstract

Rhinacanthins, derived from Rhinacanthus nasutus, widely used in traditional medicine, exhibit antifungal, anticancer, antiviral, antibacterial, and antiplatelet aggregation effects. Recently, their anti-diabetic activity was confirmed, which makes them an interesting natural alternative in the therapy of the early stage of diabetes mellitus. The aim of this study was to demonstrate the possibility of formulating orodispersible tablets (ODTs) and orodispersible films (ODFs) containing rhinacanthin-rich extract (RRE). Tablets with 50 mg or 100 mg of RRE were produced by direct compression. ODFs were manufactured by casting of Lycoat RS 720 or polyvinyl alcohol solution with RRE and additional excipients. The mechanical properties and disintegration times of the prepared formulations were studied. The effectiveness of taste masking was analyzed with an electronic tongue system. Six months simplified stability studies were performed in conditions complying to ICH guidelines. Appropriate friability of ODTs was achieved, despite low tensile strength (0.45–0.62 MPa). All prepared ODFs successfully met the acceptance criteria regarding Young’s modulus, tensile strength, and elongation at break. The observed variations in their mechanical properties were dependent on the type and quantity of polymers and plasticizers used. Disintegration time of ODTs ranged from 38.7 s to 54.2 s, while for ODFs from 24.2 to 40 s in the pharmacopoeial apparatus. Analyses made with the electronic tongue showed the significant taste-masking effect in both formulations. The addition of sucralose as a sweetener and menthol with mint flavor as a taste-masking agent was sufficient to mask an RRE’s taste in the case of ODTs and ODFs. Stability studies of ODTs packed in the PVC/Alu blisters showed a decrease in the RRE content below 90% after 6 months. However, ODFs with PVA were physicochemically stable for 6 months while being stored in Alu/Alu sachets. Our study proved for the first time the possibility of the formulation of orodispersible dosage forms with RRE, characterized by good mechanical properties, disintegration time, and appropriate taste masking.
Keywords: orodispersible tablets; orally disintegrating tablets; orodispersible films; rhinacanthin; taste masking; electronic tongue; pediatric pharmacotherapy; herbal medicines orodispersible tablets; orally disintegrating tablets; orodispersible films; rhinacanthin; taste masking; electronic tongue; pediatric pharmacotherapy; herbal medicines

Graphical Abstract

Share and Cite

MDPI and ACS Style

Suksawat, T.; Brniak, W.; Łyszczarz, E.; Wesoły, M.; Ciosek-Skibińska, P.; Mendyk, A. Orodispersible Dosage Forms with Rhinacanthin-Rich Extract as a Convenient Formulation Dedicated to Pediatric Patients. Pharmaceuticals 2024, 17, 994. https://doi.org/10.3390/ph17080994

AMA Style

Suksawat T, Brniak W, Łyszczarz E, Wesoły M, Ciosek-Skibińska P, Mendyk A. Orodispersible Dosage Forms with Rhinacanthin-Rich Extract as a Convenient Formulation Dedicated to Pediatric Patients. Pharmaceuticals. 2024; 17(8):994. https://doi.org/10.3390/ph17080994

Chicago/Turabian Style

Suksawat, Thongtham, Witold Brniak, Ewelina Łyszczarz, Małgorzata Wesoły, Patrycja Ciosek-Skibińska, and Aleksander Mendyk. 2024. "Orodispersible Dosage Forms with Rhinacanthin-Rich Extract as a Convenient Formulation Dedicated to Pediatric Patients" Pharmaceuticals 17, no. 8: 994. https://doi.org/10.3390/ph17080994

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop